Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Amphenol’s CommScope Bet Is Outperforming — and the Order Book Proves It

Jackson Burston by Jackson Burston
September 6, 2026
in Earnings, Industrial, Mergers & Acquisitions, Telecommunications
0
Amphenol Stock
0
SHARES
87
VIEWS
Share on FacebookShare on Twitter

The dust has settled on Amphenol’s 2-for-1 stock dividend, which hit shareholders’ accounts last Thursday. Yet for all the attention paid to the split mechanics, the more consequential development has been quietly building beneath the surface: the integration of CommScope’s connectivity and cable solutions business is running well ahead of internal expectations.

Management now projects the acquisition will contribute $4.6 billion to this year’s revenue, up from an earlier forecast of $4.1 billion. Perhaps more striking, what was once expected to be earnings dilution has flipped into an anticipated profit contribution of $0.30 per share — double the initial estimate. That revision speaks to a company that isn’t just growing organically but has demonstrated a knack for folding large acquisitions into its operations without missing a beat.

Record Orders Tell the Real Story

The operational numbers from the second quarter back up that thesis. Amphenol posted record revenue of $8.8 billion, up 55 percent year over year, with adjusted earnings per share of $1.35 — a 67 percent jump. Both figures landed above the top end of the company’s own guidance.

The communications solutions segment led the charge, expanding 85 percent, powered by the IT/datacom business that now accounts for 43 percent of group revenue and grew organically by 63 percent. Nearly all of the sequential growth came from AI-related products, reinforcing Amphenol’s position as a primary infrastructure beneficiary of the artificial intelligence buildout.

Perhaps the most telling data point: order intake hit a record $10.7 billion in the quarter, signaling demand from the datacom and AI segments remains robust. The company’s book-to-bill ratio — a key gauge of future revenue momentum — underscores that the AI spending cycle shows no immediate signs of tapering.

Guidance Points to Sustained Momentum

The outlook for the current quarter suggests the pace isn’t letting up. Amphenol expects third-quarter revenue between $9.3 billion and $9.4 billion, representing 50 to 52 percent growth over the prior-year period, with adjusted earnings per share of $1.40 to $1.42. Those are remarkable growth rates for a company of this market capitalization.

Should investors sell immediately? Or is it worth buying Amphenol?

Since the switch to split-adjusted trading, the stock has gained 1.5 percent, and over the past seven trading sessions it’s up 5.3 percent. Investors appear to be treating the technical adjustment not as a hurdle but as confirmation of the growth narrative. The shares closed Friday at €71.67, roughly 8.3 percent below the 52-week high of €78.13 reached in late June. The stock remains 2.3 percent above its 50-day moving average, suggesting the short-term uptrend is intact, though the recent consolidation phase hasn’t produced new highs.

Capital Discipline Amid an Acquisition Spree

What’s also notable is that Amphenol hasn’t neglected shareholders while digesting CommScope, along with the earlier acquisitions of El.Com and Wilder Technologies. During the second quarter alone, the company returned $515 million to investors — $208 million in share buybacks and $307 million in dividends. The board also confirmed a quarterly dividend of $0.25 per share, or $0.125 on a split-adjusted basis.

The flip side is a balance sheet that has become noticeably more leveraged from the dealmaking. As of June 30, total debt stood at roughly $18.81 billion against cash of $5.42 billion, putting net debt at about $13.39 billion. That’s not an alarm bell given the earnings power, but it does temper any narrative of an immaculate balance sheet.

The Next Test Arrives With Q3 Results

For now, the near-term catalysts — the split, earlier insider selling, and the raised guidance tied to the CommScope integration — have been worked through. The stock’s annualized volatility of 41 percent reflects how nervously the market is pricing in the growth trajectory, and the combination of elevated debt and an ambitious valuation leaves room for a pullback at any time.

The real proof point will come with third-quarter results, when investors see whether the company hits that $9.3 billion to $9.4 billion revenue range and whether the record order book translates into sustained growth. Given the upward revision on CommScope and an AI-driven core business growing faster than the overall company, the operational momentum suggests Amphenol is well positioned to extend its run — even if the market needs a breather first.

Ad

Amphenol Stock: Buy or Sell?! New Amphenol Analysis from October 22 delivers the answer:

The latest Amphenol figures speak for themselves: Urgent action needed for Amphenol investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

Amphenol: Buy or sell? Read more here...

Tags: Amphenol
Jackson Burston

Jackson Burston

Related Posts

Rheinmetall Stock
DAX

Rheinmetall’s Order Book Pushes Past €80 Billion as New Shell Deal Lands

September 14, 2026
Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
Next Post
CSG Stock

CSG's Order Book Is Flourishing — So Why Is the Share Price Stuck in a Rut?

Deutz Stock

Deutz's Margin Milestone Masks a Deeper Strategic Pivot as Defence and India Deals Converge

Deutsche Telekom Stock

Telekom's Tech Leadership Shuffle Arrives Amid a Pile-Up of Strategic Questions

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com